M. Colin et al., STUDY OF SODIUM ORTHOVANADATE AS A REVERSER OF MULTIDRUG-RESISTANCE ON LYMPHOBLASTIC LEUKEMIC CEM VLB(100) CELLS/, Anticancer research, 14(6A), 1994, pp. 2383-2387
The occurrence of multidrug resistance (MDR) is the major cause off fa
ilure of cancer chemotherapy. Finding a way to circumvent this problem
is now a major challenge in oncology. Multidrug resistant CEM/VLB(100
) cells accumulate 10 times less vinblastine (VLB) after 30 min than t
heir sensitive counterparts (GEM cells). At a non-cytotoxic concentrat
ion (1 mM) of sodium orthovanadate (OVN), uptake by CEM/VLB(100) cells
was increased 4 times while no effect was observed on CEM cells. The
action on VLB uptake of OVN and verapamil (VPL), an usual MDR modulato
r, was additive. In CEM/VLB(100) cells, OVN did not alter efflux. Its
cellular mechanism of action could involve a transitory stimulation of
VLB influx (x3). OVN uptake in CEM and CEM/VLB(100) cells was not sig
nificantly different and reached saturation after 30 s (180 pmol/10(6)
CEM cells and 150 pmol/10(6) CEM/VLB(100) cells). This OVN uptake was
concentration dependent IC50 of VLB and doxorubicin were decreased by
approximately 43 and 62% after 1 hour's exposure to OVN and 48 hours
of culture. Under these conditions, OVN was more efficient than OVN.